Literature DB >> 34595286

Quantification of Trypanosoma cruzi in Tissue and Trypanosoma cruzi Killing Assay.

Hisako Kayama1,2,3, Shoko Kitada1,2,3, Kiyoshi Takeda1,2,3.   

Abstract

Infection with Trypanosoma cruzi causes Chagas disease. The methods provided here allow for the quantification of T. cruzi in the liver, heart, and blood of intraperitoneally-infected mice and analysis of the killing activity of the cells infected with T. cruzi in vitro.
Copyright © 2017 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Blood; Bone marrow-derived macrophage; Heart; Killing assay; Liver; Mouse; Quantitative PCR; Trypanosoma cruzi

Year:  2017        PMID： 34595286      PMCID： PMC8438456          DOI： 10.21769/BioProtoc.2613

Source DB:  PubMed          Journal:  Bio Protoc        ISSN： 2331-8325


  12 in total

1.  Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR.

Authors:  Kara L Cummings; Rick L Tarleton
Journal:  Mol Biochem Parasitol       Date:  2003-06       Impact factor: 1.759

2.  Real-time PCR strategy for parasite quantification in blood and tissue samples of experimental Trypanosoma cruzi infection.

Authors:  Sérgio Caldas; Ivo Santana Caldas; Lívia de Figueiredo Diniz; Wanderson Geraldo de Lima; Riva de Paula Oliveira; Alzira Batista Cecílio; Isabela Ribeiro; André Talvani; Maria Terezinha Bahia
Journal:  Acta Trop       Date:  2012-05-18       Impact factor: 3.112

3.  Depletion of regulatory T cells decreases cardiac parasitosis and inflammation in experimental Chagas disease.

Authors:  Kevin M Bonney; Joann M Taylor; Edward B Thorp; Conrad L Epting; David M Engman
Journal:  Parasitol Res       Date:  2015-01-11       Impact factor: 2.289

Review 4.  Diagnosis and management of Chagas disease and cardiomyopathy.

Authors:  Antonio L Ribeiro; Maria P Nunes; Mauro M Teixeira; Manoel O C Rocha
Journal:  Nat Rev Cardiol       Date:  2012-07-31       Impact factor: 32.419

Review 5.  Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities.

Authors:  Rodolfo Viotti; Carlos Vigliano; Bruno Lococo; Maria Gabriela Alvarez; Marcos Petti; Graciela Bertocchi; Alejandro Armenti
Journal:  Expert Rev Anti Infect Ther       Date:  2009-03       Impact factor: 5.091

6.  Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome.

Authors:  Sabrina Cencig; Nicolas Coltel; Carine Truyens; Yves Carlier
Journal:  PLoS Negl Trop Dis       Date:  2011-06-28

Review 7.  Prevalence of Chagas disease in Latin-American migrants living in Europe: a systematic review and meta-analysis.

Authors:  Ana Requena-Méndez; Edelweiss Aldasoro; Elisa de Lazzari; Elisa Sicuri; Michael Brown; David A J Moore; Joaquim Gascon; Jose Muñoz
Journal:  PLoS Negl Trop Dis       Date:  2015-02-13

8.  BATF2 inhibits immunopathological Th17 responses by suppressing Il23a expression during Trypanosoma cruzi infection.

Authors:  Shoko Kitada; Hisako Kayama; Daisuke Okuzaki; Ritsuko Koga; Masao Kobayashi; Yasunobu Arima; Atsushi Kumanogoh; Masaaki Murakami; Masahito Ikawa; Kiyoshi Takeda
Journal:  J Exp Med       Date:  2017-03-29       Impact factor: 14.307

Review 9.  Immune Evasion Strategies of Trypanosoma cruzi.

Authors:  Ana Flávia Nardy; Célio Geraldo Freire-de-Lima; Alexandre Morrot
Journal:  J Immunol Res       Date:  2015-07-09       Impact factor: 4.818

Review 10.  Historical Perspectives on the Epidemiology of Human Chagas Disease in Texas and Recommendations for Enhanced Understanding of Clinical Chagas Disease in the Southern United States.

Authors:  Melissa N Garcia; Laila Woc-Colburn; David Aguilar; Peter J Hotez; Kristy O Murray
Journal:  PLoS Negl Trop Dis       Date:  2015-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.